Home › Funds › Hartford Funds Management Co LLC › GILD

Hartford Funds Management Co LLC position in GILD

GILEAD SCIENCES INC · Health Care

Hartford Funds Management Co LLC reported holding 18,155 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 0.21% of its reported portfolio and ranking #23 among its reported holdings. Hartford Funds Management Co LLC has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)18.16K sh
Reported value held$2.71M
Portfolio Weight0.21%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hartford Funds Management Co LLC's GILD position evolved

Hartford Funds Management Co LLC first disclosed a stake in GILD in Q4 2024 at 5,929 shares (US$548K). The position peaked in Q3 2026 at 18,155 shares, worth US$2.7M. Across 8 filings, Hartford Funds Management Co LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 18,155 shares valued at US$2.7M — a reduction of -281 shares quarter over quarter.. Notable position changes include a 88% trim in Q2 2025 (shares were roughly flat over the following quarter), a 1419% increase in Q3 2025 (shares rose 10% over the following quarter), a 38% increase in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 5.93K $547.68K New
Q1 2025 7.25K $812.02K Add
Q2 2025 846 $1.58M Reduce
Q3 2025 12.85K $1.43M Add
Q4 2025 17.69K $2.17M Add
Q1 2026 18.18K $2.53M Add
Q2 2026 18.44K $2.33M Add
Q3 2026 18.16K $2.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Hartford Funds Management Co LLC held GILD?

Hartford Funds Management Co LLC has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Hartford Funds Management Co LLC's current position in GILD?

As of Q3 2026, Hartford Funds Management Co LLC holds 18.16K shares of GILD (GILEAD SCIENCES INC), valued at $2.71M, representing 0.21% of its reported portfolio and ranking #23.

Has Hartford Funds Management Co LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Hartford Funds Management Co LLC reduced its position in GILD. The position peaked in Q3 2026 at 18.16K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.